Pretreatment radiomic imaging features combined with immunological indicators to predict targeted combination immunotherapy response in advanced hepatocellular carcinoma

Figure 2 Patient magnetic resonance imaging of hepatobiliary phase and plain scan phase. A: Patient one’s magnetic resonance imaging (hepatobiliary phase); B: Patient one’s magnetic resonance imaging (plain scan phase); C: Patient two’s magnetic resonance imaging (hepatobiliary phase); D: Patient two’s magnetic resonance imaging (plain scan phase). The yellow marked area represents the regions of interest.